Risk-Stratified Cardiovascular Screening Including Angiographic and Procedural Outcomes of Percutaneous Coronary Interventions in Renal Transplant Candidates
Table 2
Baseline cardiac screening procedures and subsequent MACE in renal transplant candidates stratified according to their risk status.
Variable
Total ()
Low risk ()
High risk ()
value*
Echocardiography (%)
LV-hypertrophy
181 (81.9)
49 (77.8)
132 (83.5)
0.315
LV ejection fraction (%)
0.171
Septum diameter (mm)
0.205
Noninvasive stress test (%)
204 (76.4)
56 (78.8)
148 (75.5)
0.567
Conclusive Test (%)
154 (57.7)
37 (52.1)
117 (59.7)
0.054
Stress Echocardiography (%)
122 (45.7)
27 (38)
95 (48.5)
0.130
Conclusive Test (%)
111 (41.6)
24 (33.8)
87 (44.4)
0.667
Treadmill ergometry (%)
115 (43.1)
37 (52.1)
78 (39,8)
0.073
Conclusive Test (%)
51 (19.1)
14 (19.7)
37 (18.9)
0.333
Stress test positive (%)
28 (13.7)
3 (5.4)
25 (16.9)
0.033
Coronary angiography (%)
58 (21.7)
3 (4.2)
55 (28.1)
<0.001
Sign. coronary stenosis (%)
38 (65.5)
0 (0)
38 (69.1)
0.014
Revascularization (%)
18 (31)
0 (0)
18 (32.7)
0.233
Stress test and/or coronary angiography (%)
220 (82.4)
57 (80.3)
163 (83.2)
0.585
Conclusive stress test and/or coronary angiography (%)
